ABSTRACT
Other common trade names: Anserpin; Inerpin; Novo-Reserpine; Reserfia; Sedaraupin; Serpasol; Tionsera Indications: Hypertension Category: Nondiuretic antihypertensive; Rauwolfia alkaloid Half-life: 50-100 hours Clinically important, potentially hazardous interactions with: metipranolol
Ser-Ap-Es is reserpine, hydralazine and hydrochlorothiazide
Reactions
Skin Bullous eruption [1] Edema Exanthems Flushing Lupus erythematosus (exacerbation) [1] Peripheral edema (1-10%) Pruritus Purpura Rash (sic) (<1%)
Toxic epidermal necrolysis [1] Urticaria
Other Gynecomastia Headache Parkinsonism Sialorrhea Xerostomia (>10%)
Synonyms: recombinant plasminogen activator; r-PA Trade name: Retavase (Centocor) Indications: Acute myocardial infarction Category: Thrombolytic ; Tissue plasminogen activator Half-life: 13-16 minutes Clinically important, potentially hazardous interactions with: abciximab, aspirin, bivalirudin, dipyridamole, piperacillin
Reactions
Skin Allergic reactions (sic) (<1%) Bleeding Purpura
Hematopoietic Ecchymoses
Other Anaphylactoid reactions (<1%) Headache Injection-site bleeding (1-10%)
